A novel framework for nanomedicine development
A novel framework for nanomedicine development
批准号:
10715013
负责人:
Stefan Wilhelm
金额:
$37.33万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-01 至 2028-07-31
关键词:
AreaCellsDevelopmentDiagnosticEffectivenessGoalsKineticsMedicineMethodsMissionMuscle FibersMyopathyNanotechnologyNational Institute of General Medical SciencesNucleic AcidsOrganPharmaceutical PreparationsResearchSafetySkeletal MuscleTherapeuticTherapeutic UsesTissuesbioimagingbiological systemsin vivonanomedicinenanoparticlenanoparticle deliverynanoscalenovelprogramssmall moleculespatiotemporalultra high resolution
中文摘要
项目总结
英文摘要
Project Summary
Nanomedicine is a research field centered around applying materials in the nanoscale size range (i.e.
nanoparticles) as therapeutics and diagnostics. However, a major challenge is the safe, efficient, and effective
delivery of nanoparticles to biological systems, such as cells, tissues, and organs. In this project, we will introduce
and explore a novel framework for nanomedicine development with the ultimate goal of efficiently delivering non-
viral nanoparticles to cells and tissues for safe and effective applications. Our proposed research program has
three main strands: (i) we will develop novel nanoparticles for the safe, efficient, and effective delivery of small
molecules and nucleic acid payloads to skeletal muscle cells; (ii) we will develop novel methods for super-
resolution bioimaging to study the mechanisms and kinetics of nanoparticle spatiotemporal transport in biological
systems; (iii) we will quantify safety, efficiency, and effectiveness of nanoparticle in vivo delivery. Using this novel
framework, our long-term scientific goal is to create a major breakthrough in nanomedicine by developing safer,
more efficient, and more effective nanoparticles for the non-viral delivery of small molecule-based drugs and
nucleic acid payloads to enable therapeutic applications in skeletal muscle disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
New Ultrastructural 3D Optical Imaging of Tumor Endothelium for Cancer Nanomedicine Development
-
批准号:10334986
-
项目类别:
-
资助金额:$24.49万
-
财政年份:2022
-
负责人:Stefan Wilhelm
-
依托单位:
New Ultrastructural 3D Optical Imaging of Tumor Endothelium for Cancer Nanomedicine Development
-
批准号:10573288
-
项目类别:
-
资助金额:$22.91万
-
财政年份:2022
-
负责人:Stefan Wilhelm
-
依托单位:
国内基金
海外基金
登录
查看更多内容
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:肖将尉
-
依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
-
批准号:82072862
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:徐云升
-
依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
-
批准号:82070825
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2020
-
负责人:徐西振
-
依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
-
批准号:81903002
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:王斐斐
-
依托单位:
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
-
批准号:81402419
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:杨翠霞
-
依托单位:
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
-
批准号:81271563
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:陈正光
-
依托单位:
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
-
批准号:31272541
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2012
-
负责人:王春凤
-
依托单位:
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
-
批准号:31271248
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:李伟
-
依托单位:
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
-
批准号:81160050
-
项目类别:地区科学基金项目
-
资助金额:49.0万元
-
批准年份:2011
-
负责人:邵立健
-
依托单位: